文献速递泌尿系结石

负压吸引鞘在微通道经皮肾镜取石术中的荟萃分析

Suction in mini-percutaneous nephrolithotomy: a meta-analysis from the European Association of Urology Section of Endourology.
PubMed 文献 · BJU Int · 2025-08-29

该荟萃分析比较负压吸引鞘(VAAS)与常规鞘(CAS)微通道经皮肾镜取石术(mPCNL)的结局。

要点

  • VAAS mPCNL较CAS显著缩短手术时间17.45分钟并提高结石清除率。
  • VAAS组术后发热和脓毒症风险更低,总体并发症及轻微并发症更少。
  • 两组输血率和血红蛋白下降无显著差异,VAAS住院时间缩短0.79天。

核心结论

  • VAAS mPCNL在手术时间、结石清除率和并发症方面优于CAS mPCNL。

研究设计与样本

  • 系统综述与荟萃分析,遵循PRISMA指南并在PROSPERO注册(CRD42024619780)。

主要发现

  • VAAS mPCNL显著缩短手术时间,平均减少17.45分钟(95%CI 13.12-21.79,P<0.001)。
  • VAAS mPCNL与更高的结石清除率相关(OR 1.92,95%CI 1.57-2.35,P<0.001)。
  • VAAS组术后发热率更低(OR 0.45,95%CI 0.35-0.61,P<0.001),脓毒症率更低(OR 0.45,95%CI 0.22-0.93,P=0.03)。
  • VAAS组总体并发症率显著低于CAS组(P<0.001),轻微并发症更少。
  • VAAS组住院时间更短,平均减少0.79天(P=0.03)。

关键数值与推荐

  • 输血率两组无显著差异(OR 0.78,95%CI 0.46-1.31,P=0.3)。
  • 血红蛋白下降无显著差异(0.00 g/dL,95%CI -0.22至0.22,P>0.9)。
  • 证据质量采用GRADE工具评估。

临床怎么用

  • 在微通道经皮肾镜取石术中可优先考虑使用负压吸引鞘以缩短手术时间、提高结石清除率并减少并发症。
  • 建议进一步开展高质量研究验证上述发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To conduct a meta-analysis comparing the outcomes of vacuum-assisted access sheath (VAAS) mini-percutaneous nephrolithotomy (mPCNL) vs conventional access sheath (CAS) mPCNL. METHODS: A systematic review and meta-analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines, with registration in PROSPERO (CRD42024619780). A comprehensive search identified comparative studies (randomised controlled trials and observational studies). The primary outcomes included operating time, stone-free rate (SFR) and complications. Secondary outcomes included transfusion rates, haemoglobin deficit, and length of hospital stay. Data were analysed using Review Manager V5.4, with quality of evidence assessed using the Grading of Recommendation Assessment, Development and Evaluation (GRADE) tool. RESULTS: Fourteen studies with 2510 patients (1298 in the VAAS and 1212 in the CAS mPCNL groups) were included. VAAS mPCNL significantly reduced operating time, by 17.45 (13.12-21.79) min (P < 0.001), and was associated with a higher SFR: odds ratio (OR) 1.92 (95% confidence interval [CI] 1.57, 2.35; P < 0.001). The VAAS mPCNL group also had a lower postoperative fever rate (OR 0.45 [95% CI 0.35, 0.61]; P < 0.001) and a lower sepsis rate (OR 0.45 [95% CI 0.22, 0.93]; P = 0.03). The overall complication rate for VAAS mPCNL was significantly lower than for CAS mPCNL (P < 0.001), with fewer minor complications. Hospital stay was shorter for VAAS mPCNL (mean reduction of 0.79 days; P = 0.03). There were no significant differences in transfusion rates (OR 0.78 [95% CI 0.46, 1.31]; P = 0.3) or haemoglobin deficit (0.00 g/dL [95% CI 0.22-0.22]; P > 0.9). CONCLUSION: The use of VAAS mPCNL offers significant advantages over CAS mPCNL, including shorter operating time, improved stone clearance, and reduced complications. These findings support the use of VAAS mPCNL in managing kidney stones, with further high-quality studies recommended.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Adhoni MZU, Pooley E, Byrnes K, et al. Suction in mini-percutaneous nephrolithotomy: a meta-analysis from the European Association of Urology Section of Endourology. BJU Int. 2025. PMID: 40878469. doi:10.1111/bju.16891

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。